Ticker
LYRACompany Name
LYRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -43.01M | -5585.32% | $ 770K |
3/31/2025 | $ -56.4M | -4759.32% | $ 1.19M |
12/31/2024 | $ -70.01M | -4563.95% | $ 1.53M |
9/30/2024 | $ -77.72M | -5283.28% | $ 1.47M |
6/30/2024 | $ -75.61M | -4154.29% | $ 1.82M |
3/31/2024 | $ -69.91M | -4161.25% | $ 1.68M |
12/31/2023 | $ -63.3M | -4063.16% | $ 1.56M |
9/30/2023 | $ -56.41M | -3964.16% | $ 1.42M |
6/30/2023 | $ -53.14M | -4292.57% | $ 1.24M |
3/31/2023 | $ -47.33M | -3626.82% | $ 1.3M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for LYRA THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -21.14M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Sep 30, 2021
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |